Mind Medicine (MindMed) Inc. (DFTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$17.41
Day's range
$18.49

Definium Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 8.48 M $160.28 M   100.00% 9.49%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 5.91 M $111.73 M   -9.57% 6.62%
AVORO CAPITAL ADVISORS LLC 05/15/2026 5.00 M $94.50 M   100.00% 5.60%
JANUS HENDERSON GROUP PLC 05/18/2026 3.56 M $67.23 M   100.00% 3.98%
DEEP TRACK CAPITAL, LP 05/15/2026 3.00 M $56.70 M   100.00% 3.36%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 2.50 M $47.17 M   100.00% 2.79%
STATE STREET CORP 05/15/2026 2.47 M $46.72 M   100.00% 2.77%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 2.44 M $46.12 M   100.00% 2.73%
COMMODORE CAPITAL LP 05/15/2026 2.00 M $37.80 M   100.00% 2.24%
FMR LLC 05/15/2026 1.81 M $34.20 M   100.00% 2.03%
05/15/2026 1.74 M $32.85 M   100.00% 1.95%
GOLDMAN SACHS GROUP INC 05/15/2026 1.68 M $31.67 M   100.00% 1.88%
ARROWMARK COLORADO HOLDINGS LLC 05/15/2026 1.59 M $30.14 M   100.00% 1.79%
CITADEL ADVISORS LLC 05/15/2026 1.33 M $25.20 M   100.00% 1.49%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.30 M $24.66 M   100.00% 1.46%
CANDRIAM S.C.A. 04/30/2026 1.29 M $24.45 M   100.00% 1.45%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.27 M $24.08 M   100.00% 1.43%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.20 M $22.71 M   100.00% 1.35%
MARSHALL WACE, LLP 05/15/2026 1.20 M $22.70 M   -59.65% 1.34%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 1.15 M $21.74 M   100.00% 1.29%
05/15/2026 1.10 M $20.73 M   100.00% 1.23%
HOLOCENE ADVISORS, LP 05/15/2026 1.09 M $20.64 M   100.00% 1.22%
AWM INVESTMENT COMPANY, INC. 05/15/2026 1.08 M $20.35 M   -22.56% 1.21%
CATALIO CAPITAL MANAGEMENT, LP 05/15/2026 1.04 M $19.62 M   100.00% 1.16%
AMERIPRISE FINANCIAL INC 05/15/2026 966.61 K $18.27 M   100.00% 1.08%
SIREN, L.L.C. 05/14/2026 919.49 K $17.38 M   100.00% 1.03%
05/08/2026 872.67 K $16.49 M   100.00% 0.98%
MILLENNIUM MANAGEMENT LLC 05/15/2026 846.90 K $16.01 M   100.00% 0.95%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 840.00 K $15.88 M   100.00% 0.94%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 808.72 K $15.28 M   100.00% 0.91%
ORBIMED ADVISORS LLC 05/15/2026 804.00 K $15.20 M   100.00% 0.90%
NORTHERN TRUST CORP 05/14/2026 798.99 K $15.10 M   100.00% 0.89%
BANK OF NEW YORK MELLON CORP 05/05/2026 752.92 K $14.23 M   100.00% 0.84%
WOODLINE PARTNERS LP 05/15/2026 752.79 K $14.23 M   100.00% 0.84%
NUVEEN, LLC 04/30/2026 698.13 K $13.19 M   100.00% 0.78%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 686.16 K $12.97 M   100.00% 0.77%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 598.50 K $11.31 M   100.00% 0.67%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 575.94 K $10.89 M   100.00% 0.64%
ENSIGN PEAK ADVISORS, INC 05/13/2026 546.78 K $10.33 M   108.70% 0.61%
BLACKSTONE INC. 05/15/2026 508.67 K $9.61 M   100.00% 0.57%
UBS GROUP AG 05/05/2026 493.98 K $9.34 M   100.00% 0.55%
MORGAN STANLEY 05/15/2026 438.57 K $8.29 M   100.00% 0.49%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 426.06 K $8.05 M   100.00% 0.48%
DEUTSCHE BANK AG\ 05/06/2026 411.83 K $7.78 M   100.00% 0.46%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 400.00 K $7.56 M   100.00% 0.45%
TRI LOCUM PARTNERS LP 05/18/2026 369.59 K $6.99 M   100.00% 0.41%
SUPERSTRING CAPITAL MANAGEMENT LP 05/14/2026 351.46 K $6.64 M   100.00% 0.39%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 344.17 K $6.50 M   100.00% 0.39%
PATIENT SQUARE CAPITAL LP 05/15/2026 331.00 K $6.26 M   100.00% 0.37%
STEMPOINT CAPITAL LP 05/18/2026 325.48 K $6.15 M   100.00% 0.36%

Definium Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 235 institutional investors and hedge funds held shares of Definium Therapeutics Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 8.48 M

DRIEHAUS CAPITAL MANAGEMENT LLC: 5.91 M

Avoro Capital Advisors LLC: 5 M

JANUS HENDERSON GROUP PLC: 3.56 M

Deep Track Capital, LP: 3 M

GEODE CAPITAL MANAGEMENT, LLC: 2.5 M

87.36% of Definium Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 74.18 M shares in the last 24 months. This purchase volume represents approximately $1.36 B in transactions.